Senescence in premalignant tumours
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Oncogene-induced senescence is a cellular response that may be crucial for protection against cancer development, but its investigation has so far been restricted to cultured cells that have been manipulated to overexpress an oncogene. Here we analyse tumours initiated by an endogenous oncogene, ras, and show that senescent cells exist in premalignant tumours but not in malignant ones. Senescence is therefore a defining feature of premalignant tumours that could prove valuable in the diagnosis and prognosis of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Lastly, in mice and humans, a senescence response to strong mitogenic signals, such as those delivered by certain oncogenes, prevents premalignant lesions from progressing to malignant cancers [ 16 – 19 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [16]
In the citing paper
“In addition to identifying known cell-cycle regulators, these studies identified DCR2 as a common marker of senescence (Collado et al., 2005), later shown to characterize other types of senescence.”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Collado et al., 2005
In the citing paper
“OIS or senescence induced by loss of a tumor suppressor was verified in vivo in human and murine preneoplastic lesions (Collado et al., 2005; Gorgoulis and Halazonetis, 2010; Kuilman and Peeper, 2009) and primary or treated neoplasias (Haugstetter et al., 2010).”
From Cellular Senescence: Defining a Path Forward (2019) · cites this paper as Collado et al., 2005
In the citing paper
“Studies in various mouse models, supported by correlative evidence from human- derived tissue samples, have underscored the tumour- suppressive role of OIS 81,120-123 .”
From Senescence and cancer — role and therapeutic opportunities (2022) · cites this paper as [122]
In the citing paper
“This type of oncogene-induced senescence (OIS) is frequently observed in premalignant and benign tumour tissues [37 -39] but not in advanced malignant tumours, where cancer cells have already bypassed senescence.”
From The role of cellular senescence and SASP in tumour microenvironment (2023) · cites this paper as [38]
12 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Self-citationRb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence
Narita, M., Nuñez, S., Heard, E., Narita, M., Lin, A. W., Hearn, S. A., Spector, D. L., Hannon, G. J., & Lowe, S. W. (2003) · Cell · doi:10.1016/s0092-8674(03)00401-x · Cited by 2,278
Lowe, S. W., Cepero, E., & Evan, G. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309
Tuveson, D. A., Shaw, A. T., Willis, N. A., Silver, D. P., Jackson, E. L., Chang, S., Mercer, K. L., Grochow, R., Hock, H., Crowley, D., et al. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00085-6 · Cited by 798
p19ARF links the tumour suppressor p53 to Ras
Palmero, I., Pantoja, C., & Serrano, M. (1998) · Nature · doi:10.1038/25870 · Cited by 615
Self-citationTumor induction by an endogenous K-ras oncogene is highly dependent on cellular context
Guerra, C., Mijimolle, N., Dhawahir, A., Dubus, P., Barradas, M., Serrano, M., Campuzano, V., & Barbacid, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00191-0 · Cited by 571
Self-citation
Cited by
Items 201–300 of 1,005
Cellular Senescence in Postmitotic Cells: Beyond Growth Arrest
Sapieha, P., & Mallette, F. A. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.03.003 · Cited by 193
Interplay between inflammation and cancer
Piotrowski, I., Kulcenty, K., & Suchorska, W. (2020) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/j.rpor.2020.04.004 · Cited by 187
Matsuoka, S., Oike, Y., Onoyama, I., Iwama, A., Arai, F., Takubo, K., Mashimo, Y., Oguro, H., Nitta, E., Ito, K., et al. (2008) · Genes & Development · doi:10.1101/gad.1621808 · Cited by 185
“It is well recognized that senescence as well as apoptosis is a tumorigenesis barrier (Collado et al. 2005).”
BackgroundAssessing cell and organ senescence biomarkers
de Jesus, B. B., & Blasco, M. A. (2012) · Circulation Research · doi:10.1161/circresaha.111.247866 · Cited by 187
Cellular senescence and the tumour microenvironment
Takasugi, M., Yoshida, Y., & Ohtani, N. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13268 · Cited by 172
Bennecke, M., Kriegl, L., Bajbouj, M., Retzlaff, K., Robine, S., Jung, A., Arkan, M. C., Kirchner, T., & Greten, F. R. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.06.013 · Cited by 186
“OIS can occur in vivo in various premalignant lesions of malignant melanoma, lymphoma, prostate, and lung cancer presumably having a tumor suppressive function (Braig et al., 2005; Chen et al., 2005; Collado et al., 2005; Michaloglou et al., 2005).”
BackgroundMajumder, P. K., Grisanzio, C., O'Connell, F., Barry, M., Brito, J. M., Xu, Q., Guney, I., Berger, R., Herman, P., Bikoff, R., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.06.002 · Cited by 178
Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis
Guccini, I., Revandkar, A., D'Ambrosio, M., Colucci, M., Pasquini, E., Mosole, S., Troiani, M., Brina, D., Sheibani-Tezerji, R., Elia, A. R., et al. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.10.012 · Cited by 185
Detection of Senescence-Associated Heterochromatin Foci (SAHF)
Aird, K. M., & Zhang, R. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_12 · Cited by 170
Tumor Stroma-Derived TGF-β Limits Myc-Driven Lymphomagenesis via Suv39h1-Dependent Senescence
Reimann, M., Lee, S., Loddenkemper, C., Dörr, J. R., Tabor, V., Aichele, P., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.043 · Cited by 184
The Skp2 Pathway: A Critical Target for Cancer Therapy
Cai, Z., Moten, A., Peng, D., Hsu, C.-C., Pan, B.-S., Manne, R., Li, H.-Y., & Lin, H.-K. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.01.013 · Cited by 186
Old dogs, new trick: classic cancer therapies activate cGAS
Yum, S., Li, M., & Chen, Z. J. (2020) · Cell Research · doi:10.1038/s41422-020-0346-1 · Cited by 181
Paracrine roles of cellular senescence in promoting tumourigenesis
Gonzalez-Meljem, J. M., Apps, J. R., Fraser, H. C., & Martinez-Barbera, J. P. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0066-1 · Cited by 183
ATR signaling can drive cells into senescence in the absence of DNA breaks
Toledo, L. I., Murga, M., Gutierrez-Martinez, P., Soria, R., & Fernandez-Capetillo, O. (2008) · Genes & Development · doi:10.1101/gad.452308 · Cited by 183
“At the organism level, cellular senescence has been recently shown to constitute a strong anti-tumoral barrier, which is activated early on during the initial steps of malignant transformation (Braig et al. 2005; Chen et al. 2005; Collado et al. 2005; Michaloglou et al. 2005).”
BackgroundCancer and ageing: convergent and divergent mechanisms
Serrano, M., & Blasco, M. A. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2242 · Cited by 182
Self-citationAdams, P. D. (2007) · Gene · doi:10.1016/j.gene.2007.04.020 · Cited by 176
“Activated oncogenes trigger cell senescence, thereby blocking progression to a transformed cell phenotype, notably in primary human melanocytes, human prostatic epithelium, benign human neurofibromas, mouse lymphocytes and pre-malignant mouse lung adenomas (16,25,26,30,37,79,113).”
BackgroundSenescence Regulation by the p53 Protein Family
Qian, Y., & Chen, X. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_3 · Cited by 171
TWISTing an embryonic transcription factor into an oncoprotein
Ansieau, S., Morel, A.-P., Hinkal, G., Bastid, J., & Puisieux, A. (2010) · Oncogene · doi:10.1038/onc.2010.92 · Cited by 167
Histone macroH2A isoforms predict the risk of lung cancer recurrence
Sporn, J. C., Kustatscher, G., Hothorn, T., Collado, M., Serrano, M., Muley, T., Schnabel, P., & Ladurner, A. G. (2009) · Oncogene · doi:10.1038/onc.2009.26 · Cited by 175
“ITM cells are primary fibroblasts engineered to undergo simultaneous oncogene-induced senescence on addition of the tamoxifen analog 4OHT (Collado et al., 2005).”
BackgroundResultInfluentialSelf-citationSIRT1 and AMPK in regulating mammalian senescence: A critical review and a working model
Wang, Y., Liang, Y., & Vanhoutte, P. M. (2011) · FEBS Letters · doi:10.1016/j.febslet.2010.11.047 · Cited by 177
“Senescent cells are present in premalignant tissues [26].”
BackgroundWhat We Have Learned About Pancreatic Cancer From Mouse Models
Pérez–Mancera, P. A., Guerra, C., Barbacid, M., & Tuveson, D. A. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.002 · Cited by 172
Self-citationHistone variants: emerging players in cancer biology
Vardabasso, C., Hasson, D., Ratnakumar, K., Chung, C.-Y., Duarte, L. F., & Bernstein, E. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1343-z · Cited by 165
Bellodi, C., Kopmar, N., & Ruggero, D. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.83 · Cited by 172
“…Molecular Biology Organization The EMBO Journal VOL 29 | NO 11 | 2010 1873 synthesis of important proteins required for accurate OIS, the first cellular barrier against neoplastic transformation (Braig et al, 2005; Chen et al, 2005; Collado et al, 2005), may be regulated at the translational level.”
BackgroundYe, X., Zerlanko, B., Zhang, R., Somaiah, N., Lipinski, M., Salomoni, P., & Adams, P. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01592-06 · Cited by 162
“Activated oncogenes trigger cell senescence, thereby blocking progression to a transformed cell phenotype, most notably in human melanocytes, human prostatic epithelium, mouse lymphocytes, and premalignant mouse lung adenomas (10, 12, 13, 17, 41, 58).”
BackgroundRegulation of Survival Networks in Senescent Cells: From Mechanisms to Interventions
Soto-Gamez, A., Quax, W. J., & Demaria, M. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.05.036 · Cited by 175
p53 loss promotes acute myeloid leukemia by enabling aberrant self-renewal
Zhao, Z., Zuber, J., Diaz-Flores, E., Lintault, L., Kogan, S. C., Shannon, K., & Lowe, S. W. (2010) · Genes & Development · doi:10.1101/gad.1940710 · Cited by 166
“…hematopoietic progenitor cells in vitro Loss of p53 cooperates with oncogenic Ras to promote transformation in many tissue types, although the biological basis for these genetic interactions has been controversial and may be context-dependent (Tuveson et al. 2004; Collado et al. 2005).”
BackgroundThe role of lysosomes in cancer development and progression
Tang, T., Yang, Z.-Y., Wang, D., Yang, X.-Y., Wang, J., Li, L., Wen, Q., Gao, L., Bian, X.-W., & Yu, S.-C. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00489-x · Cited by 169
Galactose‐modified duocarmycin prodrugs as senolytics
Guerrero, A., Guiho, R., Herranz, N., Uren, A., Withers, D. J., Martínez‐Barbera, J. P., Tietze, L. F., & Gil, J. (2020) · Aging Cell · doi:10.1111/acel.13133 · Cited by 172
“Galactose-modified prodrugs eliminate preneoplastic senescent cells OIS is primarily considered as a tumour suppressive mechanism (Collado et al. 2005) but senescent cells present in the tumour microenvironment can also drive tumour progression (Gonzalez-Meljem et al. 2018).”
Self-citationSTAT3 regulated ARF expression suppresses prostate cancer metastasis
Pencik, J., Schlederer, M., Gruber, W., Unger, C., Walker, S. M., Chalaris, A., Marié, I. J., Hassler, M. R., Javaheri, T., Aksoy, O., et al. (2015) · Nature Communications · doi:10.1038/ncomms8736 · Cited by 170
SIRT1 suppresses the senescence-associated secretory phenotype through epigenetic gene regulation
Hayakawa, T., Iwai, M., Aoki, S., Takimoto, K., Maruyama, M., Maruyama, W., & Motoyama, N. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116480 · Cited by 170
“precancerous tissues from both humans and mice and are progressively lost during cancer progression [3–7], thereby revealing senescence as a potent initial barrier to cancer progression.”
BackgroundIL-6-STAT3 signaling and premature senescence
Kojima, H., Inoue, T., Kunimoto, H., & Nakajima, K. (2013) · JAK-STAT · doi:10.4161/jkst.25763 · Cited by 170
“Oncogene-induced senescence has been observed in tumor cells even at early stages.(17,18) The third type of senescence is stress-induced premature senescence.”
BackgroundCellular Senescence: From Mechanisms to Current Biomarkers and Senotherapies
Lucas, V., Cavadas, C., & Aveleira, C. A. (2023) · Pharmacological Reviews · doi:10.1124/pharmrev.122.000622 · Cited by 160
Morton, J. P., Jamieson, N. B., Karim, S. A., Athineos, D., Ridgway, R. A., Nixon, C., McKay, C. J., Carter, R., Brunton, V. G., Frame, M. C., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.055 · Cited by 169
Le, O. N. L., Rodier, F., Fontaine, F., Coppe, J., Campisi, J., DeGregori, J., Laverdière, C., Kokta, V., Haddad, E., & Beauséjour, C. M. (2010) · Aging Cell · doi:10.1111/j.1474-9726.2010.00567.x · Cited by 168
“Finally, permanent growth arrest in the form of cellular senescence is a recognized tumor suppressive response (Collado et al., 2005; Michaloglou et al., 2005; Cosme-Blanco et al., 2007; Feldser & Greider, 2007) that can be induced by p16 expression (Baker et al.”
BackgroundInamura, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041259 · Cited by 160
“Growth-inhibitory responses induced by the BRAFV600E mutant show classical hallmarks of senescence (i.e., induction of both CDKN2A and senescence-associated acidic β-galactosidase activity).”
BackgroundInfluentialBar-Joseph, Z., Siegfried, Z., Brandeis, M., Brors, B., Lu, Y., Eils, R., Dynlacht, B. D., & Simon, I. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704723105 · Cited by 169
p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes
Mondal, A. M., Horikawa, I., Pine, S. R., Fujita, K., Morgan, K. M., Vera, E., Mazur, S. J., Appella, E., Vojtesek, B., Blasco, M. A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70355 · Cited by 164
“Other senescence markers previously used with other cell types, including formation of HP1-γ foci (28, 29), spontaneous induction of γ-H2AX foci (30), and mRNA expression of SASP factors, such as IL6, IL8, CXCR1, and CXCR2 (8), were also increased in the CD28–CD57+ subset (Figure 1, D–H, Supplemental Figure 4, and Sup…”
Tumor suppressor p16 INK4A is necessary for survival of cervical carcinoma cell lines
McLaughlin-Drubin, M. E., Park, D., & Munger, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310432110 · Cited by 163
“Consistent with this notion, frank tumors contain lower numbers of senescent cells than premalignant lesions (15).”
BackgroundA step-by-step microRNA guide to cancer development and metastasis
Markopoulos, G. S., Roupakia, E., Tokamani, M., Chavdoula, E., Hatziapostolou, M., Polytarchou, C., Marcu, K. B., Papavassiliou, A. G., Sandaltzopoulos, R., & Kolettas, E. (2017) · Cellular Oncology · doi:10.1007/s13402-017-0341-9 · Cited by 161
“In a KRasG12V-induced mouse model of pancreatic cancer, it was found that K-RasG12V-induced up-regulation of miR-155 can promote cell proliferation through ROS generation.”
BackgroundInfluentialHIF1α delays premature senescence through the activation of MIF
Welford, S. M., Bedogni, B., Gradin, K., Poellinger, L., Broome Powell, M., & Giaccia, A. J. (2006) · Genes & Development · doi:10.1101/gad.1471106 · Cited by 163
“When growth arrest was apparent, cells were plated for SA- gal staining and stained as previously described (Dimri et al. 1995).”
MethodRai, T. S., Cole, J. J., Nelson, D. M., Dikovskaya, D., Faller, W. J., Vizioli, M. G., Hewitt, R. N., Anannya, O., McBryan, T., Manoharan, I., et al. (2014) · Genes & Development · doi:10.1101/gad.247528.114 · Cited by 162
“4C,D), in line with incorporation of late replicating regions into compacted SAHF, H4K16ac’s ability to inhibit chromatin compaction, and a previous report correlating global decreased H4K16ac to the formation of SAHF (Shogren-Knaak et al. 2006; Chandra et al. 2012; Contrepois et al. 2012).”
Hwang, H. J., Lee, Y.-R., Kang, D., Lee, H. C., Seo, H. R., Ryu, J.-K., Kim, Y.-N., Ko, Y.-G., Park, H. J., & Lee, J.-S. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.06.019 · Cited by 157
Senescence and senotherapeutics: a new field in cancer therapy
Myrianthopoulos, V., Evangelou, K., Vasileiou, P. V. S., Cooks, T., Vassilakopoulos, T. P., Pangalis, G. A., Kouloukoussa, M., Kittas, C., Georgakilas, A. G., & Gorgoulis, V. G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.08.006 · Cited by 160
Telomerase, senescence and ageing
Shawi, M., & Autexier, C. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2007.11.007 · Cited by 172
Proteasomal and Genetic Inactivation of the NF1 Tumor Suppressor in Gliomagenesis
McGillicuddy, L. T., Fromm, J. A., Hollstein, P. E., Kubek, S., Beroukhim, R., De Raedt, T., Johnson, B. W., Williams, S. M. G., Nghiemphu, P., Liau, L. M., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.05.009 · Cited by 155
“…astrocytomas from NF1 patients were obtained. p15INK4b, a reported marker of oncogene-induced senescence, and p16INK4a, which is also commonly detected in senescent tissue, were both highly expressed in these tumors (Figure 4E and data not shown) (Collado et al., 2005; Michaloglou et al., 2005).”
Yu, Y., Schleich, K., Yue, B., Ji, S., Lohneis, P., Kemper, K., Silvis, M. R., Qutob, N., van Rooijen, E., Werner-Klein, M., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.002 · Cited by 156
“Ras-/Raf-type oncogenes evoke a senescent cell-cycle arrest as a retinoblastoma (Rb)- and p53-dependent tumor-suppressive barrier that terminates further expansion of (pre-)malignant lesions (Collado et al., 2005; Michaloglou et al., 2005; Serrano et al., 1997).”
BackgroundγH2AX as a molecular marker of aging and disease
Mah, L.-J., El-Osta, A., & Karagiannis, T. C. (2010) · Epigenetics · doi:10.4161/epi.5.2.11080 · Cited by 153
The miR-17-92 Cluster of MicroRNAs Confers Tumorigenicity by Inhibiting Oncogene-Induced Senescence
Hong, L., Lai, M., Chen, M. S., Xie, C., Liao, R., Kang, Y. J., Xiao, C., Hu, W.-Y., Han, J., & Sun, P. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1938 · Cited by 181
Banumathy, G., Somaiah, N., Zhang, R., Tang, Y., Hoffmann, J., Andrake, M., Ceulemans, H., Schultz, D., Marmorstein, R., & Adams, P. D. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01047-08 · Cited by 141
“Cellular senescence is a known tumor suppressor mechanism (7, 8, 10, 11, 13, 17, 33, 52, 56, 62, 65) and is implicated in tissue aging (8, 28, 30, 34).”
BackgroundOncogene-induced senescence results in marked metabolic and bioenergetic alterations
Quijano, C., Cao, L., Fergusson, M. M., Romero, H., Liu, J., Gutkind, S., Rovira, I. I., Mohney, R. P., Karoly, E. D., & Finkel, T. (2012) · Cell Cycle · doi:10.4161/cc.19800 · Cited by 155
Mitochondria Damage Checkpoint, Aging, and Cancer
SINGH, K. K. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1354.022 · Cited by 154
The innate immune sensor Toll-like receptor 2 controls the senescence-associated secretory phenotype
Hari, P., Millar, F. R., Tarrats, N., Birch, J., Quintanilla, A., Rink, C. J., Fernández-Duran, I., Muir, M., Finch, A. J., Brunton, V. G., et al. (2019) · Science Advances · doi:10.1126/sciadv.aaw0254 · Cited by 154
Genetic insights into OXPHOS defect and its role in cancer
Chandra, D., & Singh, K. K. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.023 · Cited by 151
“Studies conducted in various cell types provide in vivo evidence that senescence is a defining feature in premalignant tumors [122–125].”
COVID-19 and cellular senescence
Schmitt, C. A., Tchkonia, T., Niedernhofer, L. J., Robbins, P. D., Kirkland, J. L., & Lee, S. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00785-2 · Cited by 153
Extracellular matrix alterations in senescent cells and their significance in tissue homeostasis
Mavrogonatou, E., Pratsinis, H., Papadopoulou, A., Karamanos, N. K., & Kletsas, D. (2019) · Matrix Biology · doi:10.1016/j.matbio.2017.10.004 · Cited by 153
Cellular senescence and chromatin structure
Funayama, R., & Ishikawa, F. (2007) · Chromosoma · doi:10.1007/s00412-007-0115-7 · Cited by 171
“1a,b; Angello et al. 1989; Dimri et al. 1995; Narita et al. 2003; Collado et al. 2005).”
InfluentialInflammatory signaling and cellular senescence
Ren, J.-L., Pan, J.-S., Lu, Y.-P., Sun, P., & Han, J. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.011 · Cited by 148
Narita, M., & Lowe, S. W. (2005) · Nature Medicine · doi:10.1038/nm0905-920 · Cited by 177
Histone H3.3 and its proteolytically processed form drive a cellular senescence programme
Duarte, L. F., Young, A. R. J., Wang, Z., Wu, H.-A., Panda, T., Kou, Y., Kapoor, A., Hasson, D., Mills, N. R., Ma’ayan, A., et al. (2014) · Nature Communications · doi:10.1038/ncomms6210 · Cited by 152
Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence
Larsson, L. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.10.005 · Cited by 175
Senescent Stromal-Derived Osteopontin Promotes Preneoplastic Cell Growth
Pazolli, E., Luo, X., Brehm, S., Carbery, K., Chung, J.-J., Prior, J. L., Doherty, J., Demehri, S., Salavaggione, L., Piwnica-Worms, D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2970 · Cited by 147
“The presence of p16 expression is consistent with the presence of senescent cells (16, 42).”
Stem cells, senescence, neosis and self-renewal in cancer.
Rajaraman, R., Guernsey, D. L., Rajaraman, M. M., & Rajaraman, S. R. (2006) · Cancer Cell International · doi:10.1186/1475-2867-6-25 · Cited by 169
Role of microRNAs in endothelial cell pathophysiology
Staszel, T., Zapała, B., Polus, A., Sadakierska‑Chudy, A., Kieć‑Wilk, B., Stępień, E., Wybrańska, I., Chojnacka, M., & Dembińska‑Kieć, A. (2011) · Polish Archives of Internal Medicine · doi:10.20452/pamw.1093 · Cited by 151
Kwon, M.-C., & Berns, A. (2013) · Molecular Oncology · doi:10.1016/j.molonc.2013.02.010 · Cited by 147
“Likely restricted growth is mediated by cell cycle arrest and cellular senescence imposed by cell-autonomous or microenvironmental cues (Collado et al., 2005).”
BackgroundPlentz, R. R., Park, Y. N., Lechel, A., Kim, H., Nellessen, F., Langkopf, B. H. E., Wilkens, L., Destro, A., Fiamengo, B., Manns, M. P., et al. (2007) · Hepatology · doi:10.1002/hep.21552 · Cited by 147
Cao, L., Kim, S., Xiao, C., Wang, R., Coumoul, X., Wang, X., Li, W. M., Xu, X. L., Soto, J. A. D., Takai, H., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601115 · Cited by 164
“…in aging and mammary tumorigenesis Cellular senescence, which acts as a potential anticancer mechanism, can be induced by multiple conditions, including DNA damage, telomere shortening and oncogene expression (Braig et al, 2005; Chen et al, 2005; Collado et al, 2005; Michaloglou et al, 2005).”
BackgroundSharpless, N. E., & DePinho, R. A. (2005) · Nature · doi:10.1038/436636a · Cited by 159
Senescence as a therapeutically relevant response to CDK4/6 inhibitors
Wagner, V., & Gil, J. (2020) · Oncogene · doi:10.1038/s41388-020-1354-9 · Cited by 148
Self-citationEpigenetic clock analyses of cellular senescence and ageing.
Lowe, D., Horvath, S., & Raj, K. (2016) · Oncotarget · doi:10.18632/oncotarget.7383 · Cited by 147
“At present, the causes of cellular senescence in vivo are not known for certain but in vitro, cells can become senescent through (i) telomere shortening via exhaustive replication (replicative senescence)[15], (ii) overexpression of oncogene [16-18] or (iii) DNA damage [19].”
BackgroundCarragher, L. A. S., Snell, K. R., Giblett, S. M., Aldridge, V. S. S., Patel, B., Cook, S. J., Winton, D. J., Marais, R., & Pritchard, C. A. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000099 · Cited by 144
“G12VKras was not reported to induce senescence when expressed in the mouse intestine (Sansom et al, 2006), although, when expressed in the lung, premalignant adenomas were formed that express senescent markers (Collado et al, 2005).”
The role of cellular senescence and SASP in tumour microenvironment
Takasugi, M., Yoshida, Y., Hara, E., & Ohtani, N. (2023) · The FEBS Journal · doi:10.1111/febs.16381 · Cited by 144
Abbas, H. A., Maccio, D. R., Coskun, S., Jackson, J. G., Hazen, A. L., Sills, T. M., You, M. J., Hirschi, K. K., & Lozano, G. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.09.013 · Cited by 142
“Accordingly, in addition to p21, we examined expression levels of other senescent markers Dcr2, p15, p16, Dec1, and Pml via RT-PCR (Collado et al., 2005; Collado and .”
A new generation of proto-oncogenes: Cold-inducible RNA binding proteins
LLeonart, M. E. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.11.001 · Cited by 153
A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS
McMahon, M., Contreras, A., Holm, M., Uechi, T., Forester, C. M., Pang, X., Jackson, C., Calvert, M. E., Chen, B., Quigley, D. A., et al. (2019) · eLife · doi:10.7554/elife.48847 · Cited by 136
“, 1997), both of which are activated downstream of mitogenic signals to halt pre-malignant cells (Collado et al., 2005; Kuilman et al., 2010) (Figure 1D, top row).”
BackgroundKondoh, H., LLeonart, M. E., Bernard, D., & Gil, J. (2007) · PubMed · doi:10.14670/hh-22.85 · Cited by 143
“For example, oncogenic-stimuli can induce premature senescence, called oncogene induced senescence (Serrano et al., 1997; Collado et al., 2005).”
BackgroundSelf-citationColorimetric Detection of Senescence-Associated β Galactosidase
Itahana, K., Itahana, Y., & Dimri, G. P. (2013) · Methods in Molecular Biology · doi:10.1007/978-1-62703-239-1_8 · Cited by 137
“The existence of senescent cells in vivo was also demonstrated in mouse models of induction of oncogenes such as Eμ-NRAS (22), KRASV12 (23) or BRAF (24) as well as of loss of tumor suppressor genes such as PTEN (25).”
Kobayashi, Y., Mitsudomi, T., Sakao, Y., & Yatabe, Y. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu505 · Cited by 148
“Oncogenic Ras has been shown to cause senescence through the activation of the p53–p21 WAF and p16INK4A–retinoblastoma tumorsuppressor pathways [25, 26].”
BackgroundHarnessing the complexity of DNA-damage response pathways to improve cancer treatment outcomes
Al‐Ejeh, F., Kumar, R., Wiegmans, A. P., Lakhani, S. R., Brown, M. P., & Khanna, K. K. (2010) · Oncogene · doi:10.1038/onc.2010.407 · Cited by 160
Lozano-Torres, B., Estepa-Fernández, A., Rovira, M., Orzáez, M., Serrano, M., Martínez-Máñez, R., & Sancenón, F. (2019) · Nature Reviews Chemistry · doi:10.1038/s41570-019-0108-0 · Cited by 140
Self-citationKrizhanovsky, V., Xue, W., Zender, L., Yon, M., Hernando, E., & Lowe, S. W. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.048 · Cited by 138
“…and Endocrinology, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany. hyperplasia of the pituitary gland (Lazzerini Denchi et al. 2005), skin carcinoma (Collado et al. 2005), and melanocytic lesions of UV-irradiated hepatocyte growth factor/ scatter factor (HGF/SF) transgenic mice (Ha et al. 2007),…”
BackgroundChronic pancreatitis: A path to pancreatic cancer
Pinho, A. V., Chantrill, L. A., & Rooman, I. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.015 · Cited by 152
Oncogenic KRas Suppresses Inflammation-Associated Senescence of Pancreatic Ductal Cells
Lee, K. E., & Bar-Sagi, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.10.020 · Cited by 131
“It is noteworthy that in studies utilizing mouse models that are different from the one employed in this study, the endogenous expression of oncogenic KRas in the pancreas has been reported to trigger senescence in preneoplastic lesions (Collado et al., 2005; Morton et al., 2010).”
Cancer and Aging - the Inflammatory Connection
Zinger, A., Cho, W. C., & Ben-Yehuda, A. (2017) · Aging and disease · doi:10.14336/ad.2016.1230 · Cited by 136
“Nat Rev Cancer, 10: 51-57 [76] Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ,”
BackgroundMurakami, T., Inagaki, N., & Kondoh, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.869414 · Cited by 153
Molecular signaling and genetic pathways of senescence: Its role in tumorigenesis and aging
Zhang, H. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20919 · Cited by 128
“There is evidence that senescent fibroblasts can enhance the ability of pre-neoplastic cells to form malignant tumors, presumably through secretory molecules (Krtolica et al., 2001; Coppe et al., 2006).”
BackgroundShahbandi, A., Rao, S. G., Anderson, A. Y., Frey, W. D., Olayiwola, J. O., Ungerleider, N., & Jackson, J. G. (2020) · Cell Death and Differentiation · doi:10.1038/s41418-020-0564-6 · Cited by 144
Colucci, M., Sarill, M., Maddalena, M., Valdata, A., Troiani, M., Massarotti, M., Bolis, M., Bressan, S., Kohl, A., Robesti, D., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.05.015 · Cited by 164
Qian, Y., Zhang, J., Yan, B., & Chen, X. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708624200 · Cited by 131
CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation
Burns, D. M., & Richter, J. D. (2008) · Genes & Development · doi:10.1101/gad.1697808 · Cited by 134
“While senescence is usually examined in cultured cells, recent studies in animals have demonstrated that it is an important barrier to malignant transformation (Braig et al. 2005; Chen et al. 2005; Collado et al. 2005; Michaloglou et al. 2005).”
BackgroundLesina, M., Wörmann, S. M., Morton, J., Diakopoulos, K. N., Korneeva, O., Wimmer, M., Einwächter, H., Sperveslage, J., Demir, I. E., Kehl, T., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci86477 · Cited by 128
A Molecular Signature Predictive of Indolent Prostate Cancer
Irshad, S., Bansal, M., Castillo-Martín, M., Zheng, T., Aytés, À., Wenske, S., Magnen, C. L., Guarnieri, P., Sumazin, P., Benson, M. C., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006408 · Cited by 148
Nassour, J., Martien, S., Martin, N., Deruy, E., Tomellini, E., Malaquin, N., Bouali, F., Sabatier, L., Wernert, N., Pinte, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms10399 · Cited by 123
Kumar, M., Seeger, W., & Voswinckel, R. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0382ps · Cited by 127
Pinho, A. V., Rooman, I., Reichert, M., De Medts, N., Bouwens, L., Rustgi, A. K., & Real, F. X. (2011) · Gut · doi:10.1136/gut.2010.225920 · Cited by 129
“Expression of the senescence markers p53, p21, and Dec1”
BackgroundThe p53 pathway in hematopoiesis: lessons from mouse models, implications for humans
Pant, V., Quintás-Cardama, A., & Lozano, G. (2012) · Blood · doi:10.1182/blood-2012-05-356014 · Cited by 129
Mechanisms and significance of therapy-induced and spontaneous senescence of cancer cells
Mikuła-Pietrasik, J., Niklas, A., Uruski, P., Tykarski, A., & Książek, K. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03261-8 · Cited by 119
Sakamoto, H., Shimizu, J., Horio, Y., Ueda, R., Takahashi, T., Mitsudomi, T., & Yatabe, Y. (2007) · The Journal of Pathology · doi:10.1002/path.2165 · Cited by 136
“Recently, Collado et al suggested that cellular senescence, similar to cultured cells transfected with oncogenic KRAS, was the clue to preventing further progression from AAH in KRAS-targeted mice [37].”
BackgroundResultThe atypical E2F family member E2F7 couples the p53 and RB pathways during cellular senescence
Aksoy, O., Chicas, A., Zeng, T., Zhao, Z., McCurrach, M., Wang, X., & Lowe, S. W. (2012) · Genes & Development · doi:10.1101/gad.196238.112 · Cited by 130
Cellular Senescence Promotes Skin Carcinogenesis through p38MAPK and p44/42MAPK Signaling
Alimirah, F., Pulido, T., Valdovinos, A., Alptekin, S., Chang, E., Jones, E., Diaz, D. A., Flores, J., Velarde, M. C., Demaria, M., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0108 · Cited by 128
“TPA induces senescence and aSASP in humankeratinocytes and mouse skin Previous studies detected senescent cells in the dermal and stromal layers of DMBA/TPA-induced papillomas and within papillomas themselves (25, 26), implicating a role for senescent cells in SCC development.”
BackgroundSelf-citationSenescence evasion by MCF-7 human breast tumor-initiating cells
Karimi‐Busheri, F., Rasouli‐Nia, A., Mackey, J. R., & Weinfeld, M. (2010) · Breast Cancer Research · doi:10.1186/bcr2583 · Cited by 137
“Replicative senescence is considered a process triggered by telomere shortening that limits the lifespan of normal cells, but it may also serve as a block to tumorigenesis in premalignant cells [42].”
Background
Metadata
- Authors
- Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., Beach, D., & Serrano, M.
- Affiliations
- Spanish National Cancer Research Centre (ES)
- Imperial College London (GB)
- Consejo Superior de Investigaciones Científicas (ES)
- Universidad Complutense de Madrid (ES)
- Corresponding author
- Serrano, Manuel
- ORCID
- Venue
- Nature
- Published
- 2005-08-04
- Volume
- 436
- Issue
- 7051
- Pages
- 642-642
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2067117191
- Cited by
- 1,482
- References
- 7
- Citations by year
- 2026: 31 · 2025: 40 · 2024: 59 · 2023: 58 · 2022: 57 · 2021: 74 · 2020: 87 · 2019: 55 · 2018: 53 · 2017: 68 · 2016: 67 · 2015: 73 · 2014: 76 · 2013: 81 · 2012: 81
- FWCI
- 46.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, oncogene-induced senescence, oncogenic Ras, lymphoma, SUV39H1, histone methyltransferase, epigenetic regulation, melanoma, p53, PTEN mutation, prostate cancer, tumor suppression, cancer diagnosis and prognosis
- MeSH terms
- Adenocarcinoma, Alleles, Animals, beta-Galactosidase, Cell Transformation, Neoplastic, Disease Models, Animal, Heterochromatin, Lung Neoplasms, Mice, Transgenic, Precancerous Conditions, Genes, ras, Biomarkers, Tumor, Gene Expression Regulation, Neoplastic, Cellular Senescence, Disease Progression, Cyclin-Dependent Kinase Inhibitor p16, Oligonucleotide Array Sequence Analysis, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.